Results 241 to 250 of about 27,004 (255)

Incidence and Characteristics of Lymphoid Malignancies in Untreated Myelodysplastic Syndromes

Leukemia and Lymphoma, 1996
Lourdes Florensa, J L Aguilar, L Florensa   +2 more
exaly  

Clinical implications of blast immunophenotypes in myelodysplastic syndromes

Leukemia and Lymphoma, 2005
Kiyoyuki Ogata
exaly  

The role of decitabine in the treatment of myelodysplastic syndromes

Expert Opinion on Pharmacotherapy, 2007
Hagop Kantarjian, Guillermo Garcia-Manero, Ehab Atallah   +2 more
exaly  

Venetoclax and hypomethylating agent therapy in high risk myelodysplastic syndromes: a retrospective evaluation of a real-world experience

Leukemia and Lymphoma, 2020
Shyam Patel, William Shomali, Bruno C Medeiros   +2 more
exaly  

Patients with myelodysplastic syndromes treated with azacitidine in clinical practice: the AVIDA® registry

Leukemia and Lymphoma, 2015
Rami S Komrokji, Mikkael A Sekeres, Mohit Narang   +2 more
exaly  

Azacitidine in the management of patients with myelodysplastic syndromes

Therapeutic Advances in Hematology, 2012
John Lister, Salman Fazal, Cyrus Khan
exaly  

The role of azacitidine in the treatment of myelodysplastic syndromes

Expert Opinion on Investigational Drugs, 2007
James M Rossetti
exaly  

A Combination of Granulocvte Colonv-Stimulating Factor and Erythiopoietin may Synergistically Improve the Anaemia in Patients with Myelodysplastic Syndromes

Leukemia and Lymphoma, 1993
Gunnar Birgegard, Eva Hellström-Lindberg, Magnus Carlsson   +2 more
exaly  

The cytogenetics of myelodysplastic syndromes

Best Practice and Research in Clinical Haematology, 2001
Michelle M Le Beau, Harold J Olney
exaly  

Management of myelodysplastic syndromes

The American Journal of Medicine, 1987
B, Sztern, A, De Saint-Georges, A, Telerman, F, Lustman   +3 more
openaire   +2 more sources